Evaluation of sedation with propofol versus midazolam for endoscopic injection sclerotherapy in patients with liver cirrhosis: Randomized controlled trial.
- Conditions
- Esophageal varix
- Registration Number
- JPRN-UMIN000017173
- Lead Sponsor
- Department of Endoscopy, Fukushima Medical University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 20
Not provided
1. Patients with an American Society of Anesthesiologists (ASA) physical status of class 3, 4, 5. 2. Patients with active variceal bleeding. or past variceal bleeding. 3. Recurrent case after the treatment for esopageal varices. 4. Patients with severe liver failure(T.bil 4mg/gl, Child-Pugh score C). 5. Patients with severe renal failure. 6. Patients with overtminimal hepatic encephalopathy. 7. Patients with dementia, psychiatric illness. 8. Patient with comsumption of neuroactive medication. 9. Patient with drug abuse. 10. Patient with ongoing alcohol comsumption 2 weeks before the tratment. 11. Patient with allergy to propofol and midazolam. 12. Patient who have been judged as psychotic manifestation.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method minimal hepatic encephalopathy after endoscopic injection sclerotherapy
- Secondary Outcome Measures
Name Time Method